Greatbatch, Inc. (GB) is a critical component supplier to the Cardiac Rhythm Management Industry. GB's product portfolio includes batteries, capacitors, feedthroughs, low polarization coatings, assembly services, machined components and enclosures used in implantable devices such as implantable cardioverter defibrillators (ICDs) cardiac resynchronization devices and pacemakers. Sales of medical products comprise approximately 84% of the company's overall sales. In addition, GB manufacturers commercial cells and battery packs for use in oil & gas, pipeline inspection, oceanographic & seismic, military and Telematics market applications. These cells and packs provide power where the cost of failure or replacement exceeds the price of the power source
Technology Driven -- GB has set the industry standards in implantable power sources. In 1972 GB developed and manufactures the first Lithium Iodine battery in the world, which is still the system of choice in cardiac pacemakers. GB's technology leadership continued in the 1980's and 1990's with the introduction of Lithium Silver Vanadium Oxide batteries and Wet Tantalum capacitors for ICDs. The company has recently introduced its next generation high and mid-rate Q Series batteries and Nano SVO batteries into the marketplace. GB's commitment to technology leadership continues today as it invests 10% of sales in RD&E in order to introduce the next generation of medical and commercial technologies.
Market Focused -- The company has completed several market-focused acquisitions that have expanded its product portfolio in both the medical and commercial markets. The company continues to work closely with its customers in support of their development efforts and to communicate internal development initiatives.
Financial Performance and Growth Strategy -- GB's future growth will be driven by the following strategy:
- Continued technology leadership
